Baricitinib as potential treatment for 2019-nCoV acute respiratory disease (vol 395, pg e30, 2020)

被引：1

作者：

Richardson, Peter

Griffin, Ivan

Tucker, Catherine

Smith, Dan

Oechsle, Olly

Phelan, Anne

Rawling, Michael ^{[1
]}

Savory, Edward ^{[1
]}

Stebbing, Justin

机构：

[1] BenevolentAI, London, England

来源：

LANCET | 2020年 / 395卷 / 10241期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1906 / 1906

页数：1

共 45 条

[21] Acute Appendicitis During Coronavirus Disease 2019 (COVID-19): Changes in Clinical Presentation and CT Findings (vol 17, pg 1011, 2020)
Romero, Javier
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2021, 18 (11) : 1473 - 1473
[22] Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals-A retrospective cohort study (vol 132, pg 412, 2020)
Martin, D.
Konrad, M.
Adarkwah, Christian C.
Kostev, K.
POSTGRADUATE MEDICINE, 2020,
[23] Gray Matter Structural Network Disruptions in Survivors of Acute Lymphoblastic Leukemia with Chemotherapy Treatment (vol 27, pg e27, 2020)
Wang, Longsheng
Zou, Liwei
Chen, Qi
Su, Lianzi
Xu, Jiajia
Zhao, Ru
Shan, Yanqi
Zhang, Qing
Zhai, Zhimin
Gong, Xijun
Zhao, Hong
Tao, Fangbiao
Zheng, Suisheng
ACADEMIC RADIOLOGY, 2025, 32 (02) : 1160 - 1160
[24] Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study (vol 30, pg 357, 2020)
Brito, J. P.
THYROID, 2020, 30 (06) : 938 - 938
[25] Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension? (vol 318, pg E587, 2020)
Cadegiani, F. A.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2021, 320 (05): : E1006 - E1006
[26] Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients (vol 75, pg 1652, 2019)
Woldemeskel, Bezawit A.
Garliss, Caroline C.
Aytenfisu, Tihitina Y.
Johnston, Trevor S.
Cox, Andrea L.
Karaba, Andrew H.
Blankson, Joel N.
CLINICAL INFECTIOUS DISEASES, 2024, 78 (05) : 1389 - 1389
[27] Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (vol 71, pg e1, 2020)
Daley, C. L.
Iaccarino, J. M.
Lange, C.
CLINICAL INFECTIOUS DISEASES, 2020, 71 (11) : 3023 - 3023
[28] Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease (vol 50, pg 628, 2019)
Koopman, N.
Molinaro, A.
Nieuwdorp, M.
Holleboom, A. G.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (10) : 1142 - 1142
[29] Therapeutic Challenges in Patients With Noncardioembolic Acute Ischemic Stroke in Need of Double Antiplatelet Therapy for Coronary Artery Disease (vol 26, pg e213, 2019)
Darabont, Roxana Oana
Stoicescu, C.
Tiu, C.
AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) : E431 - E431
[30] Evaluation of α-Synuclein and Apolipoprotein E as Potential Biomarkers in Cerebrospinal Fluid to Monitor Pharmacotherapeutic Efficacy in Dopamine Dictated Disease States of Parkinson's Disease and Schizophrenia (vol 15, pg 2073, 2019)
Gupta, A. K.
Pokhriyal, R.
Das, U.
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 1271 - 1271

← 1 2 3 4 5 →